KTC
GDRX icon

Kistler-Tiffany Companies’s GoodRx Holdings GDRX Stock Holding History

Kistler-Tiffany Companies’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-150
Closed -$5K – 742
2021
Q2 		$5K Buy
+150
New +$5.54K ﹤0.01% 621

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Kistler-Tiffany Companies's GDRX Position: Q3 2021 in Review

Kistler-Tiffany Companies sold out of GoodRx Holdings (GDRX) in Q3 2021, closing a stake of 150 shares — an estimated $5K sold.

Kistler-Tiffany Companies first reported a position in GDRX in Q2 2021 and held it in 1 quarter. The position peaked at $5K in Q2 2021. 218 funds tracked by Wall St. Rank hold GDRX as of Q3 2021.

  • Kistler-Tiffany Companies reported no remaining GoodRx Holdings position as of Q3 2021 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 150 GoodRx Holdings shares in Q3 2021, an estimated $5K.
  • Kistler-Tiffany Companies first reported a position in GoodRx Holdings in Q2 2021 and held it in 1 quarter.
  • Kistler-Tiffany Companies's GoodRx Holdings position peaked at $5K in Q2 2021.
  • 218 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2021.

Based on Kistler-Tiffany Companies's 13F filing for Q3 2021, filed 10 Nov 2021.